Jubilant Pharma SA
Jubilant Pharma reported total assets of €17.7m at the end of the 2026 financial year (annual accounts filed with the NBB on 30 Oct 2026).
The score of Jubilant Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity 0 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Jubilant Pharma's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 30 Oct 2026
- Year ended 31 Mar 2025filed on 06 Oct 2025
- Year ended 31 Mar 2024filed on 02 Oct 2024
- Year ended 31 Mar 2023filed on 27 Oct 2023
- Year ended 31 Mar 2022filed on 27 Oct 2022
Jubilant Pharma's financial analysis
- Solvency99.4%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Jubilant Pharma
Jubilant Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0865.497.049
- VAT number
- BE0865497049
- Peppol
- Registered · 0208:0865497049 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 27 May 2004
- Registered office
- 9820 Merelbeke-Melle
- Latest accounts
- 2026 · filed on 30 Oct 2026
- Activity
- Activities of holding companies (NACE 64210)
Jubilant Pharma (SA) has been based in Merelbeke-Melle since 2004, active in: activities of holding companies. For 2026, it reports a net loss of 11,072 € and equity of €17.6m; its revenue is not published. Its solvency stands at 99.4%, above the median of its sector (55.6%).
Companies similar to Jubilant Pharma
Companies in the same business, of comparable size and area, outside its group.
- Sylphar International Activities of holding companies Sint-Martens-Latem · balance sheet €34.3m
- UCB Fipar Anderlecht · balance sheet €38.6m
- Catalent Gosselies Holding Activities of holding companies Charleroi · balance sheet €4.80m
- Telemis Holding Activities of holding companies Ottignies-Louvain-la-Neuve · balance sheet €14.2m
- "Nest" Activities of holding companies Deinze · balance sheet €13.5m
- Dental Discovery Enterprises Activities of holding companies Knokke-Heist · balance sheet €2.00m
- Biognost Filia Activities of holding companies Kortrijk · balance sheet €17.3m
- Hospidex Group Activities of holding companies Tienen · balance sheet €45.0m
Frequently asked questions about Jubilant Pharma
What is the revenue of Jubilant Pharma?
Jubilant Pharma files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Jubilant Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0865497049 for Jubilant Pharma, if the company is VAT-registered. Its company number (CBE) is 0865.497.049.
Where is the registered office of Jubilant Pharma?
According to the CBE register, the registered office of Jubilant Pharma is in 9820 Merelbeke-Melle.
What is the equity of Jubilant Pharma?
At the close of the 2026 financial year, the equity of Jubilant Pharma amounts to 17,629,449 €, a solvency of 99.4% of total assets.
Who manages Jubilant Pharma?
The register lists 3 active mandates at Jubilant Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Jubilant Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →